COVID-19 Tests Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2020-2030

Pages:   Published: May 02, 2022 Report Code: GDME705MM

The COVID-19 tests market size was valued at $49.37 billion in 2021. Severe Acute Respiratory Syndrome Coronavirus, SARS‐CoV‐2 has spread worldwide leading the World Health Organization (WHO) to declare a pandemic. The disease caused by SARS‐CoV‐2, coronavirus disease 2019 (COVID‐19), presents flu‐like symptoms which can become serious in high‐risk individuals. It is a rapidly evolving situation across the globe and has impacted the majority of the world’s population.

Infection is transmitted through large droplets generated during coughing and sneezing by symptomatic patients, but may also occur in asymptomatic individuals, as well as before the onset of symptoms. Global vaccination efforts started near the end of 2020 and continued throughout 2021. Currently, the standard of test for diagnosing COVID-19 is reverse transcriptase (RT)-PCR which is used globally due to its flexibility in price, widespread installed base of capital equipment, ease of throughput, and ability to scale up.

COVID-19 tests market overview

COVID-19 tests market overview

For more insights on this report, download a free report sample

What are the market dynamics in the COVID-19 tests market?

The incidence of COVID-19 is expected to decrease due to greater public awareness, vaccination, continued use of public health measures including mask use and social distancing. Late 2020 and 2021 saw stabilization of supply chains for COVID-19 testing, establishing a strong market, particularly for NAATs. Later development of Rapid Antigen Detection Tests and Point-of-Care NAATs have seen the market shift away from the test base previously dominated by high-volume, core laboratory-based NAATs.

What is the regional outlook of the COVID-19 tests market?

The key regions in the COVID-19 Tests market are North America, Europe, Asia Pacific, South and Central America, and Middle East and Africa.

COVID-19 tests market in North America

The COVID-19 PCR Tests market is expected to contract across North America beyond 2022. Barring the rise of a more severe virus variant, PCR testing is expected to experience a plateau in the short term due to successful efforts in public vaccination campaigns. In the long term, COVID-19 is expected to recede into a seasonal, endemic disease with a cyclical infection pattern such as that observed with the flu. In North American countries, analysis of healthcare system invoice data indicates that the majority of COVID-19 PCR Tests are performed via NAATs.

COVID-19 tests market in Europe

The patchwork spread of COVID-19 across Europe has resulted in a patchwork recovery with substantial differences in the number of incident cases between countries. In general, sources indicate that NAATs are largely used throughout Europe for the diagnosis of COVID-19. 

COVID-19 tests market in Asia Pacific

The APAC COVID-19 PCR Tests market is anticipated to sustain the incidence rate in the Asia Pacific region. Due to the successful efforts of public vaccination campaigns, the COVID-19 PCR testing could present a graph plateauing in the near future. In the years to come, COVID-19 is expected to recede into a seasonal, endemic disease with a cyclical infection pattern. According to several financial reports of diagnostic manufacturers, positive growth can be seen in the APAC region indicating a recovery of markets. In most APAC countries, sources indicate that NAATs are typically used for COVID-19 diagnostic screening. 

COVID-19 tests market in South and Central America

In South American countries, the majority of COVID-19 PCR Tests are performed via NAATs.

COVID-19 tests market in Middle East and Africa

The Middle East & Africa COVID-19 PCR tests market is anticipated to sustain the incidence rate in 2021-22. All the Middle East & African countries are expected to exhibit an increase in sales. Saudi Arabia faced a substantial fall yet managed to stay stable.

What are the key segments in the COVID-19 tests market?

The key segments in the COVID-19 tests market are Singleplex Nucleic Acid Amplification Tests (NAATs), NAAT Point of Care (POC), Multiplex NAATs.

COVID-19 tests market, by segments

COVID-19 tests market, by segments

 

For more segment insights, download a free report sample

What are the key companies in the COVID-19 tests market?

Some of the key companies in the COVID-19 tests market are F. Hoffmann-La Roche Ltd, Abbott Laboratories, Hologic Inc, Becton Dickinson and Co, DiaSorin SpA, bioMerieux SA, Danaher Corp, Qiagen NV, PerkinElmer Inc, and Luminex Corp.

COVID-19 tests market, by key companies

COVID-19 tests market, by key companies

To know more about key companies, download a free report sample

Market Report Scope

Market size (Year – 2021) $49.37 billion
Forecast period 2021-2030
Key regions North America, Europe, Asia Pacific, South and Central America, and Middle East and Africa
Key segments Singleplex Nucleic Acid Amplification Tests (NAATs), NAAT Point of Care (POC), and Multiplex NAATs
Key companies F. Hoffmann-La Roche Ltd, Abbott Laboratories, Hologic Inc, Becton Dickinson and Co, DiaSorin SpA, bioMerieux SA, Danaher Corp, Qiagen NV, PerkinElmer Inc, and Luminex Corp

Market Report Scope

This report provides:

  • Currently marketed COVID-19 Tests and evolving competitive landscape.
  • Insightful review of the key industry trends.
  • Annualized total COVID-19 Tests market revenue by segment and market outlooks from 2020-2030.
  • Market level data on units, average selling prices and market values.
  • Global, regional, and country-level market-specific insights.
  • Qualitative market-specific information with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
  • SWOT analysis for COVID-19 Tests market.
  • Competitive dynamics insights and trends provided for the COVID-19 Tests market.
  • Country specific overview of the healthcare system.
  • Country specific reimbursement policies.
  • Country specific medtech regulatory landscape.

Reasons to Buy

  • Understand the impact of COVID-19 on the COVID-19 Tests market.
  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving the COVID-19 Tests market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the COVID-19 Tests market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
  • Track device sales in the global and country-specific COVID-19 Tests market from 2015-2030.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.

Key Players

F. Hoffmann-La Roche Ltd

Abbott Laboratories

Hologic Inc

Becton Dickinson and Co

DiaSorin SpA

bioMerieux SA

Danaher Corp

Qiagen NV

PerkinElmer Inc

Luminex Corp

Thermo Fisher Scientific Inc

Quidel Corp

Integrated DNA Technologies

Bio-Rad Laboratories Inc

GenMark Diagnostics Inc

OSANG Healthcare Co Ltd

BGI Genomics Co Ltd

Altona Diagnostic GmbH

Others

Frequently Asked Questions

Request a Free Sample
$7500

Can be used by individual purchaser only

$22500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

GDPR + CCPA Compliant

Personal and transaction information are kept safe from unauthorised use.

Recently Viewed Reports

Looking to stay on top of industry & market trends?

Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.